Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

1. Catumaxomab

   James E. Frampton

   Шарҳ мақолаNanoparticle-Based Drug DeliveryDrugs20121 иқтибос

   ABIABI:AkademIndex/openalex/2012.review-article.000001

2. Catumaxomab: First Approval

   Yahiya Y. Syed

   Шарҳ мақолаCancer therapeutics and mechanismsDrugs20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.review-article.000255